CARYX | GIPRX | CARYX / GIPRX | |
Total Expense Ratio | 0.77 | 1.23 | 63% |
Annual Report Gross Expense Ratio | 0.77 | 1.30 | 59% |
Fund Existence | 11 years | 18 years | - |
Gain YTD | 12.748 | 9.635 | 132% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.5B | 580M | 431% |
Annual Yield % from dividends | 2.28 | 3.65 | 63% |
Returns for 1 year | 10.33 | 8.18 | 126% |
Returns for 3 years | 34.93 | 34.83 | 100% |
Returns for 5 years | 11.68 | 22.19 | 53% |
Returns for 10 years | 37.19 | 50.22 | 74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DTCYX | 21.47 | 0.11 | +0.51% |
BNY Mellon Sust US Equity Y | |||
FTRIX | 30.29 | 0.13 | +0.43% |
Fidelity Advisor Mega Cap Stock I | |||
PREFX | 86.41 | 0.29 | +0.34% |
T. Rowe Price Tax-Efficient Equity | |||
MSVOX | 6.25 | -0.01 | -0.16% |
Morgan Stanley Vitality Portfolio R6 | |||
ASCQX | 17.38 | -0.04 | -0.23% |
American Century Small Company I |